Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Retained Earnings (2020 - 2025)

Biofrontera has reported Retained Earnings over the past 6 years, most recently at -$127.9 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$127.9 million for Q4 2025, down 8.97% from a year ago — trailing twelve months through Dec 2025 was -$127.9 million (down 8.97% YoY), and the annual figure for FY2025 was -$127.9 million, down 8.97%.
  • Retained Earnings for Q4 2025 was -$127.9 million at Biofrontera, up from -$133.6 million in the prior quarter.
  • Over the last five years, Retained Earnings for BFRIW hit a ceiling of -$64.4 million in Q3 2021 and a floor of -$133.6 million in Q3 2025.
  • Median Retained Earnings over the past 5 years was -$103.2 million (2023), compared with a mean of -$100.0 million.
  • Biggest five-year swings in Retained Earnings: crashed 91.61% in 2021 and later fell 0.81% in 2022.
  • Biofrontera's Retained Earnings stood at -$78.9 million in 2021, then decreased by 0.81% to -$79.5 million in 2022, then fell by 25.32% to -$99.6 million in 2023, then fell by 17.82% to -$117.4 million in 2024, then fell by 8.97% to -$127.9 million in 2025.
  • The last three reported values for Retained Earnings were -$127.9 million (Q4 2025), -$133.6 million (Q3 2025), and -$126.9 million (Q2 2025) per Business Quant data.